Showing 2,662 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C transmission & prevention

HCV reinfection is common among HIV-positive gay men in Europe

News
29 October 2013
New & experimental hepatitis C treatment

European Medicines Agency advises on compassionate use of sofosbuvir

Editor's pick
European Medicines Agency
26 October 2013
New & experimental hepatitis C treatment

FDA panel backs Gilead hepatitis C drug sofosbuvir

Editor's pick
Reuters
26 October 2013
Hepatitis C treatment

FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients

Editor's pick
Janssen press release
25 October 2013
New & experimental hepatitis C treatment

Merck Receives Breakthrough Therapy Designation for MK-5172/MK-8742, an Investigational Oral Combination Regimen for the Treatment of Chronic Hepatitis C Virus (HCV) Infection

Editor's pick
Merck press release
23 October 2013
New & experimental hepatitis C treatment

Faldaprevir demonstrates good early response in genotype 1 HIV/HCV co-infection

News
22 October 2013
New & experimental hepatitis C treatment

Simeprevir with interferon effective for HIV/HCV co-infected people with genotype 1 hepatitis C

News
21 October 2013
Improving HIV care

Ensuring good-quality HIV care in Europe: where can we improve?

News
19 October 2013
Treatment guidelines

New EACS treatment guidelines strike balance between individual choice and public health, say writers

News
18 October 2013
Hepatitis B

Men-only hepatitis B mutation explains higher cancer rates

Editor's pick
Eurekalert Inf Dis
18 October 2013
New & experimental hepatitis C treatment

New drugs will bring revolution in hepatitis C treatment

News
18 October 2013
The search for a cure

Bristol-Myers Squibb launches initiative to support search for cure in chronic viral diseases

Editor's pick
Bristol-Myers Squibb press release
17 October 2013
HIV prevention policy

Eastern Europe facing quadruple epidemic while governments do nothing, warns UN Special Envoy

News
16 October 2013
Hepatitis C treatment

The uncomfortable truth: Hepatitis C in England

Editor's pick
Hepatitis C Trust
15 October 2013
Hepatitis & HIV

Guidelines for the Management of Hepatitis Viruses in Adults Infected with HIV 2013

Editor's pick
British HIV Association
15 October 2013
Hepatitis C treatment

Hepatitis C Trust says strategy urgent as related liver disease on the rise

Editor's pick
The Guardian
14 October 2013
New & experimental hepatitis C treatment

Interferon-free therapy alters lipid metabolism, glucose homeostasis in chronic HCV patients

Editor's pick
Healio Hepatology
14 October 2013
New & experimental hepatitis C treatment

Enter the Nonspecialist: Will Evolving Hepatitis C Therapies Reduce the Need for Specialized Care?

Editor's pick
Clinical Care Options (requires registration)
14 October 2013
New & experimental hepatitis C treatment

Predicting response to acute hepatitis C treatment in HIV/HCV co-infected people

News
14 October 2013
Hepatitis C symptoms & diagnosis

Lack of HCV Genetic Diversity Tied to Higher Liver Disease Risk in Women With HIV

Editor's pick
NATAP
12 October 2013
New & experimental hepatitis C treatment

Daclatasvir works well against hepatitis C either with interferon or in all-oral regimen

News
10 October 2013
New & experimental hepatitis C treatment

Idenix Shares Fall as J&J Buys Rival Hepatitis C Therapy

Editor's pick
Bloomberg
8 October 2013
New & experimental hepatitis C treatment

Investigational interferon-free regimen demonstrates undetectable hepatitis C virus in all patients reaching end of treatment in ongoing Phase II trial

Editor's pick
Boehringer-Ingelheim press release
8 October 2013
New & experimental hepatitis C treatment

Janssen Acquires Investigational NS5A Inhibitor for the Treatment of Hepatitis C from GlaxoSmithKline

Editor's pick
Janssen press release
8 October 2013